Skip to main content
BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.300
+0.100 (8.33%)
Apr 29, 2026, 2:28 PM IDT

BioLineRx Revenue

In the year 2025, BioLineRx had annual revenue of $1.18M USD, down -95.92%. BioLineRx had revenue of $194.00K in the quarter ending December 31, 2025, a decrease of -98.35%.

Revenue
$1.18M
Revenue Growth
-95.92%
P/S Ratio
8.33
Revenue / Employee
$49.17K
Employees
24
Market Cap
31.33M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.18M-27.76M-95.92%
Dec 31, 202428.94M24.14M502.92%
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evogene 12.28M
Clal Biotechnology Industries 11.55M
BioLight Life Sciences 21.00K
Can-Fite BioPharma 1.29M
XTL Biopharmaceuticals 3.26M
Geffen Residence & Renewal 78.00K
Revenue Rankings

BioLineRx News

More News